[1]
2021. Pharmacotherapeutic Options for Philadelphia Chromosome-Positive CML. Journal of Cancer Research Updates. 7, 2 (Aug. 2021), 49–58. DOI:https://doi.org/10.6000/1929-2279.2018.07.02.3.